PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Aspira Women's Health Inc. (AWH)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS04537Y1091
CUSIP04537Y109
SectorHealthcare
IndustryDiagnostics & Research

Highlights

Market Cap$43.08M
EPS-$1.81
Revenue (TTM)$9.15M
Gross Profit (TTM)$4.32M
EBITDA (TTM)-$18.65M
Year Range$2.31 - $6.75
Target Price$5.25
Short %1.50%
Short Ratio5.40

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Aspira Women's Health Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Aspira Women's Health Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%NovemberDecember2024FebruaryMarchApril
-30.00%
22.58%
AWH (Aspira Women's Health Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Aspira Women's Health Inc. had a return of -16.67% year-to-date (YTD) and -35.24% in the last 12 months. Over the past 10 years, Aspira Women's Health Inc. had an annualized return of -23.15%, while the S&P 500 had an annualized return of 10.55%, indicating that Aspira Women's Health Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-16.67%6.33%
1 month-4.49%-2.81%
6 months-31.86%21.13%
1 year-35.24%24.56%
5 years (annualized)-29.86%11.55%
10 years (annualized)-23.15%10.55%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202432.35%-26.85%-21.52%
202317.54%-11.94%-32.63%28.30%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AWH is 32, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of AWH is 3232
Aspira Women's Health Inc.(AWH)
The Sharpe Ratio Rank of AWH is 3131Sharpe Ratio Rank
The Sortino Ratio Rank of AWH is 3939Sortino Ratio Rank
The Omega Ratio Rank of AWH is 3939Omega Ratio Rank
The Calmar Ratio Rank of AWH is 2828Calmar Ratio Rank
The Martin Ratio Rank of AWH is 2424Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Aspira Women's Health Inc. (AWH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


AWH
Sharpe ratio
The chart of Sharpe ratio for AWH, currently valued at -0.36, compared to the broader market-2.00-1.000.001.002.003.00-0.36
Sortino ratio
The chart of Sortino ratio for AWH, currently valued at 0.08, compared to the broader market-4.00-2.000.002.004.006.000.08
Omega ratio
The chart of Omega ratio for AWH, currently valued at 1.01, compared to the broader market0.501.001.501.01
Calmar ratio
The chart of Calmar ratio for AWH, currently valued at -0.37, compared to the broader market0.001.002.003.004.005.006.00-0.37
Martin ratio
The chart of Martin ratio for AWH, currently valued at -1.04, compared to the broader market0.0010.0020.0030.00-1.04
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.91, compared to the broader market-2.00-1.000.001.002.003.001.91
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.77, compared to the broader market-4.00-2.000.002.004.006.002.77
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.33, compared to the broader market0.501.001.501.33
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.46, compared to the broader market0.001.002.003.004.005.006.001.46
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.61, compared to the broader market0.0010.0020.0030.007.61

Sharpe Ratio

The current Aspira Women's Health Inc. Sharpe ratio is -0.36. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-0.36
1.91
AWH (Aspira Women's Health Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Aspira Women's Health Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-99.94%
-3.48%
AWH (Aspira Women's Health Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Aspira Women's Health Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aspira Women's Health Inc. was 100.00%, occurring on Jul 16, 2009. The portfolio has not yet recovered.

The current Aspira Women's Health Inc. drawdown is 99.94%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Nov 8, 20002157Jul 16, 2009
-25.04%Oct 3, 200012Oct 18, 200014Nov 7, 200026

Volatility

Volatility Chart

The current Aspira Women's Health Inc. volatility is 21.50%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%NovemberDecember2024FebruaryMarchApril
21.50%
3.59%
AWH (Aspira Women's Health Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Aspira Women's Health Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items